Breast Cancer Tumor Care Observational Programme

A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

NCT00309491 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

NCT00256698 ·Status: COMPLETED ·Phase: PHASE3

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

NCT00295646 ·Status: COMPLETED ·Phase: PHASE3

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

NCT00300508 ·Status: COMPLETED ·Phase: PHASE3

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

NCT00638391 ·Status: COMPLETED

Patient's Anastrozole Compliance to Therapy Programme

NCT00555867 ·Status: TERMINATED

Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study

NCT00255463 ·Status: COMPLETED ·Phase: PHASE2

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

NCT00544986 ·Status: COMPLETED ·Phase: PHASE4

Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

NCT00542594 ·Status: TERMINATED

Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT)

NCT00857012 ·Status: COMPLETED

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

NCT05549505 ·Status: COMPLETED ·Phase: PHASE2

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

NCT00291759 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

NCT00871858 ·Status: COMPLETED ·Phase: PHASE2

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

NCT01081509 ·Status: COMPLETED

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

NCT01016665 ·Status: COMPLETED ·Phase: NA

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

NCT00078832 ·Status: COMPLETED ·Phase: PHASE3

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

NCT00077025 ·Status: COMPLETED ·Phase: PHASE2

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

NCT00921115 ·Status: COMPLETED ·Phase: PHASE2

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

NCT01151215 ·Status: TERMINATED ·Phase: PHASE2

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects

NCT00497458 ·Status: UNKNOWN ·Phase: PHASE2

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

NCT00291798 ·Status: COMPLETED ·Phase: PHASE2

Trial of Perioperative Endocrine Therapy - Individualising Care

NCT02338310 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice

NCT00767585 ·Status: COMPLETED

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3